Aspira Womens Health Inc. buy krebskrebs
Start price
24.01.22
/
50%
€14.78
Target price
24.01.23
€24.00
Performance (%)
-57.36%
End price
25.01.23
€6.30
Summary
This prediction ended on 25.01.23 with a price of €6.30. Massive losses of -57.36% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aspira Womens Health Inc. | - | - | - | - |
| iShares Core DAX® | -0,98 % | -4,72 % | 4,79 % | 53,02 % |
| iShares Nasdaq 100 | 1,16 % | 1,88 % | 20,23 % | 95,41 % |
| iShares Nikkei 225® | -1,59 % | -5,39 % | 31,35 % | 54,65 % |
| iShares S&P 500 | -0,28 % | 0,33 % | 13,91 % | 66,55 % |
Comments by krebskrebs for this prediction
In the thread Vermillion Inc. diskutieren
In the thread Trading Vermillion Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten